SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
, 16:01
859.90
0
VOLUME 308,222
LIVE
NSE
, 16:01
859.80
0
VOLUME 5,415,702
Business News on Ranbaxy Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Daiichi Sankyo to offload stake in Sun Pharma 

8.15 pm | 20 Apr 2015 |  Source: PTI

As part of the deal, Ranbaxy shareholders were to receive 0.8 Sun Pharma shares for every Ranbaxy share they held. Daiichi Sankyo, which had acquired ...

No plan to merge SPARC with Sun Pharma: Dilip Shanghvi 

7.18 pm | 25 Mar 2015 |  Source: CNBC-TV18

With Sun Pharma-Ranbaxy merger complete, Sun is now India's largest and the world's fifth largest drug maker with combined revenue of USD 5.14 billion...

Focus will be to regain regulators' confidence: Sun Pharma

5.43 pm | 25 Mar 2015 |  Source: Moneycontrol.com

Shanghvi, who replaced Mukhesh Ambani as India’s richest man on March 4, said the company's "most important focus" would be to regain the confidence...

Sun Pharma to delist Ranbaxy on completion of $ 4 bn merger

2.35 pm | 25 Mar 2015 |  Source: PTI

The merger has fortified Sun Pharma's position as the world's fifth largest speciality generic pharmaceutical firm and the top ranking Indian pharma c...

Sun Pharma open to large acquisitions post Ranbaxy deal

2.26 pm | 25 Mar 2015 |  Source: Reuters

The company will look to invest more than USD 300 million in research and development and is not considering any job cuts post the close of the deal, ...

Eyeing over $300mn R&D spend; Ranbaxy to delist: Sun Pharma 

1.22 pm | 25 Mar 2015 |  Source: Moneycontrol.com

The merger has fortified Sun Pharma’s position as the world’s fifth-largest specialty generic pharmaceutical company and the top Indian Pharma com...

Sun-Ranbaxy USD 4 billion merger completed

6.17 pm | 24 Mar 2015 |  Source: PTI

The two firms have received nod from the Competition Commission for sale of seven brands to Emcure Pharma to comply with the fair trade watchdog's con...

See Rs 400cr increase in top line over next few yrs: Hetero 

3.29 pm | 24 Mar 2015 |  Source: CNBC-TV18

The company has 20 facilities across the globe with portfolio of more than 200 products in 138 countries....

RBI allows Sun to transfer Ranbaxy's overseas investments

1.34 pm | 24 Mar 2015 |  Source: PTI

Sun Pharmaceutical Industries has received RBI nod for transfer of overseas investments of Ranbaxy to it and issue its shares to the non-resident shar...

Sun-Ranbaxy deal gets final CCI nod; Emcure to buy 7 brands

8.26 pm | 23 Mar 2015 |  Source: PTI

In an order issued on Monday, CCI also approved the deal with Emcure, which would purchase the 'divestment products' that were ordered to be sold in a...

FTC passes final order in USD 4 billion Sun-Ranbaxy deal

10.38 pm | 20 Mar 2015 |  Source: PTI

US anti-trust regulator FTC has passed its final order settling charges that Sun Pharma's USD 4 billion deal to acquire Ranbaxy Laboratories could res...

Ranbaxy merger: Sun Pharma readies new leadership team

2.34 pm | 12 Mar 2015 |  Source: PTI

While the leadership team is comprised mainly from the representatives of Sun Pharma, it also has executives from Ranbaxy, drawing upon expertise, exp...

12
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.